Navigation Links
Researchers control growth rate of replacement blood vessels, tissues
Date:3/6/2008

ANN ARBOR. Mich.---Researchers have discovered a way to control the growth rate of replacement tissue and the formation of new blood vessels, which solves one of the vexing problems of growing replacement tissue to treat injuries and trauma in humans.

The procedure could be used in bone grafts, tissue replacement, dental procedures or for diabetics or elderly patients who experience wound healing problems, said William Giannobile, professor at the University of Michigan School of Dentistry and College of Engineering, and corresponding author of the paper. Peter Ma, U-M professor with appointments in engineering and dentistry, is co-author and principal investigator on the National Institutes of Health project.

"If you have such a large defect that your body can't completely heal, this is a way to augment and dose a natural wound healing protein," Giannobile said.

Researchers put platelet-derived growth factor into nanoparticles and then attached them to a lattice-like, biodegradable scaffold. In experiments, the growth factor recruited cells that stimulate the body's own machinery responsible for healing, said Ma, whose lab developed the scaffold and the nanoparticles.

As the tissue grows, it crawls into the scaffold, which eventually dissolves.

"Growth factor is typically dumped in and releases over a period of hours," said Giannobile, who also directs the Michigan Center for Oral Health Research. "With certain wounds you might want a lot (of growth factor) in the beginning, and with others you might want a little released over a longer period of time. We've basically found a way to dial up or dial down the release rate of these growth factors."

Platelet derived growth factor is FDA-approved for treatment of diabetic ulcers and to promote bone repair in tooth-associated defects, but time-release delivery has been a big problem. Ma said the one of the keys was finding a way to preserve the biologica
'/>"/>

Contact: Laura Bailey
baileylm@umich.edu
734-647-1848
University of Michigan
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...SCHAFFHAUSEN, Switzerland, Nov. 30 /PRNewswire-Fir...today announced that its 2010 annual general meeti...h 10, 2010 at 3:00 p.m. Central European time at t...8002 Zurich, Switzerland. Registered shareholders ...ntitled to vote at the annual general meeting. Ad...
(Date:11/30/2009)... tiny period of time between the registration of a...onscious recognition of it ― between the tim...an apple. Our minds lag behind our eyes, but by ho...the world around us? , Some estimates say the ... 500 milliseconds. A new study by Tel Aviv Univers...
(Date:11/30/2009)...ies report safe transplant results in animals , ...o new studies in animals suggest that stem cells f...d could help treat some lung and heart disorders. ... can differentiate into a long list of different k... of the Samsung Medical Center in Seoul, Korea, co...
(Date:11/30/2009)...HORT HILLS, N.J., Nov. 30 Kemin Fo...gies, Inc. and OmniActive Health Technologies, Ltd...nt of their dispute. The parties agree that Kemin,...ed "Process for Isolation, Purification and Recrys...oresin and Uses Thereof" and the reissues of that ...
(Date:11/30/2009)... , NASHVILLE, Tenn., Nov. 30 Du...t gifts for the holidays. For a loved one with Alz... members and friends oftentimes struggle with appr... , one of the leading providers of senior living r...d dementia care , offers these suggestions. ,, ...
Breaking Medicine News(10 mins):Health News:Now you see it, now you know you see it 2Health News:Gift Ideas for Loved Ones with Alzheimer's/Dementia 2
...PLEASANTON, Calif., FRAMINGHAM, Mass., SYDNEY, Feb...on (Nasdaq: THOR ), a world leader in device-,ba...ve, support and restore,failing hearts, and HeartW...nitive merger agreement under which Thoratec will,...
...ical collaboration and integration of electronic m...out NE Ohio , , CLEVELAND, Feb. 13 Cleveland Cli... MinuteClinic, the pioneer and largest provider of...enient, seven-day-a-week option for those with acu...
... Mr Keith Borowsky, an eminent... Medical School has chosen a Mecmesin MultiTest 10...uct research on a new orthopaedic prosthesis for s...n at the University of Brighton Medical School has...
...laint filed in Superior Court for the Commonwealth...ire-FirstCall/ - QLT Inc. (NASDAQ: QLTI ; TSX: Q...al Hospital Corporation, doing business as Massach...Inc. QLT Phototherapeutics (Canada), Inc. was a pr...
...d gender also affect chances of having debilitatin...ay News) -- Being overweight may increase the risk...ults, suggests a U.S. study that included 22,211 p...have migraines than those with smaller waistlines....
... The non-profit Hospice By The...ve care, is offering specialized trainings in end-...sionals in Marin, San Francisco, and Sonoma counti...ngs, which are repeated monthly, contact Hospice,s...
Other Medicine News:Health News:Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million; 2Health News:Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million; 3Health News:Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million; 4Health News:Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million; 5Health News:Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million; 6Health News:Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million; 7Health News:Cleveland Clinic Enters into Agreement with MinuteClinic 2Health News:Cleveland Clinic Enters into Agreement with MinuteClinic 3Health News:Cleveland Clinic Enters into Agreement with MinuteClinic 4Health News:Force Tester Shoulders The Burden 2Health News:QLT announces that it is named as a defendant in an action 2Health News:QLT announces that it is named as a defendant in an action 3Health News:Belly Fat May Make Migraines More Likely 2Health News:Hospice By The Bay Offers Health Care Professionals Free Training in End-of-Life Care 2Health News:Hospice By The Bay Offers Health Care Professionals Free Training in End-of-Life Care 3
(Date:11/30/2009)... , NEW YORK, Nov. 30 Repo...report is available in its catalogue: ,, Infla...nce the Immune Response ,, http://www.reportl...s-That-Suppress-or-Balance-the-Immune-Response.htm...er attacking an individual body or producing an ex...
(Date:11/30/2009)... , WALTHAM, Mass., Nov. 30 /PRNewswire/ -...e global authority on medical technology market in...injectable market declined by almost 5% over 2008 ...a result of the economic crisis. The market will, ... return to the strong pre-recession growth rates o...
(Date:11/30/2009)... , WAYNE, N.J. and CHICAGO, Nov. 30 /PRNewswire...ual Meeting of the Radiological Society of North...Inc. announced the enrollment of the first patient...valuate the efficacy and safety of florbetaben (BA...yloid plaques in the brain, which are a pathologic...
Breaking Medicine Technology:Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 2Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 3Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 4Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 5Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3Internet May Be Newest Venue for Teen Tobacco Exposure 52122 1Internet May Be Newest Venue for Teen Tobacco Exposure 52122 2Internet May Be Newest Venue for Teen Tobacco Exposure 52122 3Feel Fun Fit 26 Fabulous 21 At the 2009 Womens Health Conference 52117 1Feel Fun Fit 26 Fabulous 21 At the 2009 Womens Health Conference 52117 2Feel Fun Fit 26 Fabulous 21 At the 2009 Womens Health Conference 52117 3Our brain looks at eyes first to identify a face 9280 1Our brain looks at eyes first to identify a face 9280 2Our brain looks at eyes first to identify a face 9280 3
...YVILLE, Calif., Dec. 17 Neurobiological,Technolog...ed that an independent,Data Safety Monitoring Boar...trials of Viprinex(TM) for the treatment of acute ... result, the company has terminated further enroll...e data before evaluating the,potential for any fut...
...YORK, LONDON and HAMILTON, Bermuda, Dec. 16 Celt...announced today that the databases have been locke...uble-blinded studies of XERECEPT (R) (corticoreli...dema, as well as an initial database lock on the o... efficacy. , , The results of these studies a...
Other Medicine Technology:Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis 2Celtic Pharma Announces Update on Status of XERECEPT(R) Program Sale Planned in 2009 2
Micro Suture Forceps
Mini Blades
Leica M520 OH3
VM 500
Medicine Products: